Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb

Blood. 1996 Mar 15;87(6):2221-34.

Abstract

To provide insight into the mechanisms by which c-myb regulates hematopoiesis, we analyzed the expression of markers for multiple hematopoietic lineages in differentiating parental embryonic stem (ES) cells and in ES cells transfected with c-myb or with a mutant c-myb deficient in DNA binding and assessed the ability of these cells to undergo hematopoietic commitment and colony formation. Undifferentiated ES cells transfected with intact c-myb, but not cells transfected with mutant c-myb, expressed CD34, c-kit, GATA1, and flt3 mRNA as well as surface CD34, c-kit, and flt3 product. In contrast, the kinetics of GATA-2 mRNA expression was identical in parental and Myb-transfected ES cells. Transient expression assays suggested transactivation of gene expression dependent on interaction with Myb binding sites in the CD34 and GATA1 5' flanking regions. Undifferentiated parental and c-myb mutant-transfected ES cells were not clonogenic, whereas c-myb transfectants formed erythromyeloid colonies in methylcellulose cultures in the absence of added hematopoietic growth factors and, at higher frequency, in the presence of kit and flt-3 ligands. Colony formation was suppressed by treatment with antisense oligodeoxynucleotides specifically downregulating c-kit and flt-3 expression. These findings indicate that c-myb regulates hematopoietic commitment and progenitor cell proliferation and differentiation through the activation of certain genes that define the stem/progenitor cell compartment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, CD34 / biosynthesis
  • Antigens, CD34 / genetics
  • Antigens, Differentiation / biosynthesis*
  • Antigens, Differentiation / genetics
  • Base Sequence
  • Biomarkers
  • Cell Differentiation / drug effects
  • Cell Division
  • Cell Line
  • Cell Lineage
  • Clone Cells
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / physiology*
  • Erythroid-Specific DNA-Binding Factors
  • GATA1 Transcription Factor
  • Gene Expression Regulation* / drug effects
  • Growth Substances / pharmacology
  • Hematopoiesis / drug effects
  • Hematopoiesis / physiology*
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Mice
  • Molecular Sequence Data
  • Oligonucleotides, Antisense / pharmacology
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-myb
  • Recombinant Fusion Proteins / metabolism
  • Stem Cells / classification
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Trans-Activators / biosynthesis
  • Trans-Activators / genetics
  • Trans-Activators / physiology*
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Transcriptional Activation
  • Transfection

Substances

  • Antigens, CD34
  • Antigens, Differentiation
  • Biomarkers
  • DNA-Binding Proteins
  • Erythroid-Specific DNA-Binding Factors
  • GATA1 Transcription Factor
  • GATA1 protein, human
  • Gata1 protein, mouse
  • Growth Substances
  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myb
  • Recombinant Fusion Proteins
  • Trans-Activators
  • Transcription Factors